Global Immuno In-Vitro Diagnostics (IVD) Market, ByProduct Type (Reagents, Instruments, Data Management Software, Services), Immunodiagnostics Technique (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Enzyme-Linked ImmunoSpot Assays, Radioimmunoassay, Western Blotting), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Drug Testing/Pharmacogenomics, HIV/AIDS, Autoimmune Diseases, Nephrology, Others), End User (Hospital Laboratories, Clinical Laboratories, Point Of Care Testing, Patient Self-Testing, Academic Institutes, Others),Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Immuno In-Vitro Diagnostics (IVD) : Global Immuno In-Vitro Diagnostics (IVD) Market
Immuno in-vitro diagnostics (IVD) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 23.97 billion by 2028 and will grow at a CAGR of 4.78% in the above mentioned forecast period.
Immuno in-vitro diagnostics test are generally performed on blood or tissue samples to identify disease or any serious condition. These devices have next generation sequencing tests which can help them to sense genomic variation in person DNA.
The increasing geriatric population and high growth in the prevalence of chronic and infectious diseases is amongst the important factors intensifying the growth and demand of immuno in-vitro diagnostics (IVD) market. In addition, the high adoption of fully automated and POC instruments in emerging regions and increasing geriatric population are also contributing to the growth in the global market over the forecast period of 2021 to 2028. Also the rising awareness regarding disease diagnosis and increasing R&D investments by industry players to launch new IVD products are also enhancing the growth of the market. Furthermore, the higher disposable income and expansion of automated in vitro diagnostic systems for laboratories and hospitals to give resourceful, precise and error-free diagnosis are also one of the significant factors fueling the growth of the immuno in-vitro diagnostics (IVD) market. Increases vulnerability to acquiring various diseaseswill also make sure high industry growth over the forecast period.
The rising significance of companion diagnostics, growing awareness regarding immuno in-vitro diagnostics (IVD) techniques and rapid development of condition-specific markers and tests are offering significant growth opportunities for the market in the forecast period of 2021 to 2028.
However, the poor reimbursement scenarioand high price of the immunodiagnostic products will curb the growth of the immuno in-vitro diagnostics (IVD) market, whereas the stringent government regulations and various operational barriers faced in conducting diagnostic tests (IVD) has the potential to challenge the growth of the immuno in-vitro diagnostics (IVD) market.
This immuno in-vitro diagnostics (IVD) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on immuno in-vitro diagnostics (IVD) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Immuno In-Vitro Diagnostics (IVD) Market Scope and Market Size
Immuno in-vitro diagnostics (IVD) market is segmented on the basis of product type, immunodiagnostics technique, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the immuno in-vitro diagnostics (IVD) market is segmented into reagents, instruments, data management software and services. Instruments have further been segmented into semi-automated instruments, fully automated instruments and other instruments.
- Immuno in-vitro diagnostics (IVD) market is also segmented on the basis of immunodiagnostics technique into enzyme-linked immunosorbent assay, rapid tests, enzyme-linked immunospot assays, radioimmunoassay and western blotting. Enzyme-linked immunosorbent assay have further been segmented into chemiluminescence immunoassays, fluorescence immunoassays and colorimetric immunoassays.
Based on application, the immuno in-vitro diagnostics (IVD) market is segmented into infectious diseases, diabetes, oncology, cardiology, drug testing/pharmacogenomics, HIV/AIDS, autoimmune diseases, nephrology and others.
The end user segment of immuno in-vitro diagnostics (IVD) market is segmented into hospital laboratories, clinical laboratories, point of care testing, patient self-testing, academic institutes and others. Clinical laboratories have further been segmented into large/reference laboratories, medium-sized laboratories and small laboratories.
Immuno In-Vitro Diagnostics (IVD) Market Country Level Analysis
Immuno in-vitro diagnostics (IVD) market is analyzed and market size insights and trends are provided by country, product type, immunodiagnostics technique, application and end user as referenced above.
The countries covered in the immuno in-vitro diagnostics (IVD)market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the immuno in-vitro diagnostics (IVD) marketowing to theincreasing disease prevalence and increased consumer awareness within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of therising healthcare awareness as well as increasing patients going for early diagnosis and high chronic disease occurrence within this particular region.
The country section of the immuno in-vitro diagnostics (IVD) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Immuno in-vitro diagnostics (IVD) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for immuno in-vitro diagnostics (IVD) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the immuno in-vitro diagnostics (IVD) market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Immuno in-vitro Diagnostics (IVD) Market Share Analysis
Immuno in-vitro diagnostics (IVD) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to immuno in-vitro diagnostics (IVD) market.
The major players covered in the immuno in-vitro diagnostics (IVD) marketreport are F. Hoffmann-La Roche Ltd, Danaher, Abbott, Siemens Healthcare Private Limited, Thermo Fisher Scientific, Inc., Johnson & Johnson Services, Inc., BD, Bio-Rad Laboratories, Inc., Sysmex Corporation, bioMérieux SA, DiaSorin S.p.A., Ortho Clinical Diagnostics,Agilent Technologies, Inc., QIAGEN, Bayer AG, Cepheid, Leica Biosystems Nussloch GmbH, Quidel Corporation, CARIS LIFE SCIENCES, and GenomeMe among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
